TRVI · Trevi Therapeutics, Inc. · Documents

$12.94 +0.17 (+1.33%) At close · Oct 22

Market Cap

$1.85B

142.48M

Volume · Oct 22 1.18M Avg daily vol (3M) 1.97M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
8-K	—	2023-05-11	—
10-Q	—	2023-05-11	2023-03-31
DEF 14A	—	2023-05-01	2023-06-28
8-K	—	2023-04-14	2023-04-13
10-K	—	2023-03-16	2022-12-31
8-K	—	2023-03-16	—
10-Q	—	2022-11-10	2022-09-30
8-K	—	2022-11-10	—
8-K	—	2022-09-23	2022-09-22
8-K	—	2022-09-19	—
8-K	—	2022-08-11	—
10-Q	—	2022-08-11	2022-06-30
8-K	—	2022-06-29	—
8-K	—	2022-06-23	—
8-K	—	2022-05-16	2022-05-13
10-Q	—	2022-05-12	2022-03-31
8-K	—	2022-05-12	—
DEF 14A	—	2022-04-29	2022-06-23
8-K	—	2022-04-07	2022-04-06
8-K	—	2022-03-17	—
10-K	—	2022-03-17	2021-12-31
8-K	—	2022-03-16	—
8-K	—	2022-02-24	—
8-K	—	2022-02-01	—
8-K	—	2022-01-14	2022-01-10
8-K	—	2022-01-05	—
10-Q	—	2021-11-10	2021-09-30
8-K	—	2021-11-10	—
8-K	—	2021-10-19	2021-10-15
8-K	—	2021-10-01	2021-09-30
8-K	—	2021-08-12	—
10-Q	—	2021-08-12	2021-06-30
8-K	—	2021-08-09	—
8-K	—	2021-07-09	—
8-K	—	2021-07-07	2021-07-06
8-K	—	2021-06-21	2021-06-18
8-K	—	2021-06-21	2021-06-16
8-K	—	2021-05-13	—
10-Q	—	2021-05-13	2021-03-31
DEF 14A	—	2021-04-27	2021-06-16
8-K	—	2021-04-02	2021-03-29
10-K	—	2021-03-25	2020-12-31
8-K	—	2021-03-25	—
8-K	—	2021-03-22	2021-03-18
8-K	—	2020-11-12	2020-11-11
10-Q	—	2020-11-12	2020-09-30
8-K	—	2020-10-21	—
8-K	—	2020-09-11	2020-09-08
8-K	—	2020-08-13	—
10-Q	—	2020-08-13	2020-06-30

Showing 51–100 of 110 filings

Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 18 filings 18 filers Visit website Investor relations